The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Asian Currencies Subdued as Yen Weakens Ahead of Fed, BOJ Decisions
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Trump Signs Order to Cut Routine Childhood Vaccines
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Treasury Buyback Fails to Cool Long-Term Yields
TetherMax Expands into Asian Market Following Rebranding, Names Actor Yun Siyun as Brand Ambassador
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Blackstone Eyes $2 Billion ZO Skin Health Sale
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Brent Oil Tops $100 as Middle East Conflict Threatens Supply
Longsys Raises $903 Million in Hong Kong IPO as Shares Debut Flat
Norway Core Inflation Rises to 3% in August
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 



